Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.42 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.42 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.40 |
| ▸ | TTR | P02766 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1004872 | 1.00 | ERN1 (0.44) | ERN1ALDH1A1TSHRTDP1KDM4E | |
| SCHEMBL9839130 | 0.87 | MAPT (0.44) | ERN1ALDH1A1TSHRTDP1KDM4E | |
| SCHEMBL5950414 | 0.85 | ALDH1A1 (0.50) | ERN1ALDH1A1TSHRTDP1KDM4E | |
| SCHEMBL10897941 | 0.84 | ERN1 (0.41) | ERN1ALDH1A1TSHRTDP1CYP1A2 | |
| SCHEMBL13243654 | 0.84 | IDO1 (0.50) | ERN1ALDH1A1TSHRTDP1CYP1A2 | |
| SCHEMBL1002684 | 0.84 | ERN1 (0.53) | ERN1ALDH1A1TSHRTDP1MAPT | |
| SCHEMBL29708049 | 0.84 | ERN1 (0.53) | ERN1ALDH1A1TSHRTDP1MAPT | |
| SCHEMBL20562170 | 0.79 | ALDH1A1 (0.49) | ERN1ALDH1A1TSHRCYP1A2MAPT | |
| SCHEMBL4257992 | 0.79 | ALOX15 (0.43) | KDM4ECYP1A2MAPTCYP2C9CYP2C19 | |
| SCHEMBL11306283 | 0.78 | MAPT (0.45) | ERN1ALDH1A1TSHRTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | HENKEL AG & CO. KGAA (DE) | 2024-03-05 | — | — | US | claimed |
| CN-114746069-A | Three-step multi-tone hair dyeing method | 汉高股份有限及两合公司 | 2022-07-12 | — | — | CN | claimed |
| EP-4003286-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-06-01 | — | — | EP | claimed |
| CN-114173750-A | Improving the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2022-03-11 | — | — | CN | claimed |
| EP-4291951-A1 | TWO-COMPONENT SYSTEM | Xetos AG (DE) | 2023-12-20 | — | — | EP | disclosed |
| CN-116830040-A | Photopolymerizable compositions | 西托斯股份公司 | 2023-09-29 | — | — | CN | disclosed |
| EP-4043961-B1 | 2K SYSTEM | XETOS AG (DE) | 2023-08-16 | — | — | EP | disclosed |
| WO-2022233824-A1 | NAPHTHALENE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER | INSTITUT CURIE (FR) | 2022-11-10 | — | — | WO | disclosed |
| WO-2022171823-A1 | PHOTOPOLYMERIZABLE COMPOSITION | XETOS AG (DE) | 2022-08-18 | — | — | WO | disclosed |
| WO-2022171814-A1 | TWO-COMPONENT SYSTEM | XETOS AG (DE) | 2022-08-18 | — | — | WO | disclosed |
| CN-114746069-A | Three-step multi-tone hair dyeing method | 汉高股份有限及两合公司 | 2022-07-12 | — | — | CN | disclosed |
| EP-4003286-A1 | INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL | Henkel AG & Co. KGaA (DE) | 2022-06-01 | — | — | EP | disclosed |
| CN-114173750-A | Improving the stability of agents for treating keratin materials | 汉高股份有限及两合公司 | 2022-03-11 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11918671-B2 | Multi-tone hair dyeing method in three steps | TYR, HAO2, HAAO | ERN1 4459/4885ALDH1A1 111/4885TSHR 3526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.